Medicalgorithmics S.A. — M&A Activity 2026

May 11, 2026

Report Content Subject: Information on the conclusion of a letter of intent byMedicalgorithmics S.A.

Current report no.: 16/2026

Date of preparation: 11 May 2026

Legal basis: Article 17(1) of the MAR Regulation - confidentialinformation.

The Management Board of Medicalgorithmics S.A. with its registeredoffice in Warsaw "Company" informs that on 11 May 2026 the Companyentered to a non-binding letter of intent with a Luxembourg-basedholding company of a medical technology group, majority-owned by apublic company listed in Sweden "Investor".

The letter of intent concerns a "Proposed Transaction" and specifically"intends to explore in good faith a potential strategic transactioninvolving the Company, including a possible strategic investment in, oracquisition of shares in, the Company, subject in all respects tofurther discussions, due diligence, internal approvals, applicable legalrequirements and definitive documentation". The parties contemplate anevaluation period of up to ninety (90) days from the date ofcountersignature of the letter of intent.

Prior to receipt of the letter of intent, the Company and the Investorentered into a non-disclosure agreement and held discussions, includingtechnical discussions regarding the Company's technology, with theInvestors subsidiary. The Investor also reviewed publicly availableinformation concerning the Company.

The letter of intent is non-binding and does not create any obligationon either party to enter into, continue, negotiate, approve, or completeany transaction, except for certain provisions expressly identified asbinding in the letter of intent.